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Background: It often remains unclear to investigators how their research contributes to the work of the commissioner.
We initiated the ‘Risk Model’ case study to gain insight into how a Dutch National Institute for Public Health and the
Environment (RIVM) project and its knowledge products contribute to the commissioner’s work, the commissioner
being the Health Care Inspectorate. We aimed to identify the alignment efforts that influenced the research project
contributions. Based on the literature, we expected interaction between investigators and key users to be the most
determining factor for the contributions of a research project.
Methods: In this qualitative case study, we analyzed the alignment efforts and contributions in the Risk Model project
by means of document analysis and interviews according to the evaluation method Contribution Mapping. Furthermore,
a map of the research process was drafted and a feedback session was organized. After the feedback session with
stakeholders discussing the findings, we completed the case study report.
Results: Both organizations had divergent views on the ownership of the research product and the relationship
between RIVM and the Inspectorate, which resulted in different expectations. The RIVM considered the use of the risk
models to be problematic, but the inspectors had a positive opinion about its contributions. Investigators, inspectors,
and managers were not aware of these remarkably different perceptions. In this research project, we identified six
relevant categories of both horizontal alignment efforts (between investigators and key users) as well as vertical
alignment efforts (within own organization) that influenced the contributions to the Inspectorate’s work.
Conclusions: Relevant alignment efforts influencing the contributions of the project became manifest at three levels:
the first level directly relates to the project, the second to the organizational environment, and the third to the formal
and historical relationship between the organizations. Both external and internal alignments influence the contributions
of a research project. Based on the findings, we recommend that research institutes invest in a reflective attitude
towards the social aspects of research projects at all levels of the organization and develop alignment strategies to
enhance the contributions of research.
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For knowledge institutes such as the Dutch National
Institute for Public Health and the Environment (RIVM),
it is important to know what factors influence the im-
pact of their research. This article aims to give insight
into the process of a government-commissioned RIVM
research project and the relevant alignment efforts needed
to enhance its contributions to the commissioner’s work.
The RIVM is an independent knowledge institute with
expertise in the fields of public health, infectious diseases,
healthcare, medicines, lifestyle, nutrition, and environ-
mental safety. Being a governmental institution, the RIVM
conducts research on behalf of other governmental orga-
nizations to support them in their policymaking and
supervisory tasks. One of the RIVM’s principal contracting
agencies is the Health Care Inspectorate (hereafter:
Inspectorate), which supervises the quality of health
services, prevention measures, and medical products in
the Netherlands. In a yearly program cycle, the Inspectorate
submits knowledge questions to be answered by research
conducted by the RIVM (Additional file 1 Yearly cycle
for RIVM research in commission of the Health Care
Inspectorate). For commissions to the RIVM, the Minister
of Health puts a dedicated budget at the Inspectorate’s
disposal, which means that the Inspectorate cannot use
this budget for other purposes. Although RIVM investi-
gators and inspectors interact during all phases of the
research project, the Inspectorate, as the commissioning
body, does not have authority over the research methods
used, nor the outcome of studies as is laid down in the
Act on the RIVM [1].
These days, the Inspectorate has to account for the
effectiveness of its supervisory methods [2]. In its long-
range plans, the Inspectorate expresses its objective to
develop and use scientific knowledge for evidence-based
supervision [3,4]. Consequently, research projects commis-
sioned to the RIVM are often intended to contribute to
the scientific basis of the Inspectorate’s work.
An evidence-based approach assumes that use of know-
ledge will lead to better professional practices resulting in
both better and more legitimate outcomes [5,6]. This
assumption strengthens the investigator’s expectations
with regard to how research products will be used: investi-
gators will produce scientific knowledge for the profes-
sionals, who will be eager to use it to improve their
professional practices. However, this expectation often
does not come true: utilization of research findings is diffi-
cult to achieve in practice. By now, the widely recognized
difficulties in actual contributions of research have led to
extensive research on knowledge utilization in healthcare
and public health. Knowledge institutes use the insights
from this research field in specific strategies to enhance
the likelihood that their research will indeed contribute
to improvements in practice; we call these strategiesalignment efforts [7]. The RIVM also recognized the
importance of alignment efforts and established them into
procedures and guidelines on an institutional level. Some
examples of such official alignment efforts are periodic
meetings between managers of the RIVM and the commis-
sioning organizations, training of project leaders where
they learn to keep in touch with the commissioner’s
contact person, and guidelines for the periodic progress
reports and final RIVM products.
The RIVM’s aim is to support the Inspectorate in its
supervisory tasks and tries to enhance its contribution
to the Inspectorate’s work by specific alignment efforts.
However, it often remains unclear for RIVM investigators
to what extent their research really contributes and how
its contributions could be improved. As a part of an
RIVM strategic research project on improving know-
ledge utilization, we initiated a case study to explore
how a RIVM project proceeded [8].
The objective of this study was to gain insight into
how an RIVM project, including its knowledge products,
contributed to the Inspectorate’s work and to identify
the alignment efforts in the research project that influ-
enced the research process and its contributions. In
this article, we first present our study framework, the
method used, and our findings in a ‘map’ of the RIVM
research project. We describe the research project’s
contributions and the alignment efforts that influenced
the project. We finally reflect on the method used, espe-
cially on the feedback session with inspectors, investiga-
tors, and managers, as well as on the study limitations.
In our conclusions, we provide also suggestions for
improving research projects and its contributions.
Study framework
The starting point for our study was the awareness that
interaction between investigators and the intended users
of research is generally considered the decisive factor
to enhance the contribution of research. Based on the
Interaction Model for research utilization in the field of
health policymaking, de Goede et al. [9] developed an
analytical framework that consists of a distinct policy
network and a distinct research network. In the overlap
of these networks, interaction takes place between the
policy network and research network promoting research
utilization (Figure 1).
In a way, this model also describes the context of
RIVM research for the Inspectorate: both are distinct
organizations with their own networks and they overlap
at different levels. The two networks ‘RIVM’ and
‘Inspectorate’ specifically overlap in the research projects
commissioned by the Inspectorate. Both organizations
recognize the importance of interaction during the research
project for the contributions of a research project as
reflected in institutionalized alignment efforts.
Barriers:
Expectation, Transfer, Acceptance, Interpretation




Figure 1 The interaction model by de Goede et al. (2010) [9]. De Goede et al. visualized the distinct research and the policy networks as
partially overlapping circles. In the Interaction Model, policymaking is an interactive and incremental process and extensive interaction between
investigators and policymakers promotes research utilization. In the overlap of these networks, interaction takes place between the policy
network and research network promoting research utilization.
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[9] is an adequate model to describe the overall relation-
ship between the RIVM and Inspectorate organizations,
this model did not offer a method to zoom in on the
overlap of the two networks to analyze and explain the
course of a research project. We needed a model for the
complex research process with many different actors on
different organizational levels evolving in a certain period.
Contribution Mapping (CM), recently formulated by Kok
and Schuit [7], offers a useful framework for our study,
taking into account the social context of a research project
and contains a three-phase process model of the research
process. CM also includes a practical method for analysis,
which we applied to our case study.
During the research process, the research network and
policy network form a hybrid world (Figure 2). Research
is a process of co-creation where actors are, on the one
hand, the investigators who perform the research and, on
the other, the linked actors who in some way are
connected to the project. Investigators and linked actors
go through a joint process of co-creation in a research
project. In this process of knowledge production, the
three-phase process model distinguishes three demarcated
phases in which typical activities take place:
i. Formulation phase: activities to initiate the research
process, including funding, prioritization, and
commissioning;
ii. Production phase: activities to realize the knowledge
products;
iii. Knowledge extension phase: activities to make the
knowledge available to potential users and to initiate
and stimulate utilization.It is difficult to assess the final impact of research on ac-
tion for health and to measure the actual use of research
products. A direct link from a research product to im-
proved practices is often hard to trace. To handle this attri-
bution problem, Kok and Schuit introduced the concept of
contribution to action: “Contribution to action refers to
the activities which turn novel combination of knowledge
into a ‘going concern’, as part of practices, a component of
successful innovation, as an element in decision making
and their implementation” [7]. All phases of the research
process can be relevant for contributions to health prac-
tices and Kok and Schuit distinguished four categories of
research-related contributions:
i. Changes in abilities and actions of involved and
linked actors due to the research activities;
ii. The contributed knowledge products as such;
iii. Contributions through the utilization of the produced
knowledge by investigators and linked actors;
iv. Contributions through utilization at distance by
non-linked actors.
In research projects, actors are usually aware of
problems in research transmission and utilization. They
therefore design alignment efforts; during all phases of
the research process, both investigators and linked ac-
tors undertake specific actions to enhance the desired
contributions of the research process and the likeli-
hood that the research indeed contributes and that the
research products are used. Actors have their own
actor-scenario which may have (decisive) influence on
the process in all phases and thus on the contributions
of the research process, on the knowledge product and/or
Figure 2 The three-phase process model by Kok and Schuit (2012) [7]. We cite the description of Kok and Schuit to clarify the figure: “The
three-phase process model. In the graphical representation of the three-phase process model, the two vertical lines separate the three phases.
The search process narrows when a research proposal is formulated. At the beginning of the production phase, the search processes may widen
again, before they are narrowed and the knowledge products are realized. During the production phase, there may already be some dissemination
and uptake of emerging knowledge. After the knowledge products have been realized, the extension phase commences with dissemination and
utilization in evolving actor-scenarios. Investigators are inside the research process, while linked actors are outside but able to interact in the process.
Both investigators and linked actors can connect the research process to evolving actor-scenarios” [7].
Hegger et al. Health Research Policy and Systems 2014, 12:8 Page 4 of 15
http://www.health-policy-systems.com/content/12/1/8utilization of the knowledge product. In practice, actors
are not only involved in one research project, but are part
of their own network and organizational environment and
their actor-scenario continuously evolves. Kok and Schuit
describe knowledge utilization as “incorporating knowledge
into an actor-scenario as a means of contributing to its
strength and scope” [7]. For incorporation into an actor-
scenario, research knowledge has to be translated into a
form and content that fits the actor-scenario. Alignment
efforts will be most effective to enhance contributions of
research knowledge when investigators and involved actors
recognize and take account of the different actor-scenarios.
Based on the three-phase process model, Kok and
Schuit developed a method to systematically evaluate
the complex research process and the contributions of
the research to action. According to this CM evaluation
method, the investigators of a research project and the
linked actors, such as potential key-users, are inter-
viewed after an initial document analysis. Based on the
findings, a map of the research process is drafted taking
alignment efforts and an estimation of the contributions
into account. In a feedback session, the draft map is pre-
sented to relevant stakeholders to validate the findings
and to identify inconsistencies. Next, the contributionmap is finalized and used for learning, improvement,
and accountability purposes [7].
In our case study, we used the three-phase process
model of CM as a study framework and we used the
CM evaluation method to investigate the RIVM project
‘Risk Model’, commissioned by the Inspectorate, and its
contributions. We specifically focused on the interaction
between actors, especially the investigators and key
users, using the theoretical concept of CM that align-
ment is the precondition for the contributions of a
research project. Alignment efforts to create alignment
are important to enhance its contributions; Kok and
Schuit described various alignment efforts such as
“engaging potential users in setting research priorities,
formulating research and interpreting results, employing
double-role actors in research and disseminating research
results to potential key-users” [7]. In our case study, we in-
ductively identified the alignment efforts that appeared to
be relevant for the RIVM-Inspectorate relationship.
Methods
To explore the contributions of a RIVM project to the
work of the Inspectorate, we used a qualitative case
study approach, including document analysis and semi-
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Risk Model project, a small project with a limited num-
ber of involved actors commissioned by the Inspectorate
during three consecutive years.Contribution map
For the document analysis, we manually analyzed docu-
ments from the project archives within the RIVM and
relevant public documents of the Inspectorate in order to
reconstruct the course of events with respect to the project.
We interviewed actors from RIVM and the Inspectorate
involved in the project (n = 10), namely the investigators
(RIVM project leader and another RIVM investigator), the
key users (four inspectors), and two RIVM managers and
two managers from the Inspectorate as relevant infor-
mants. We used a topic list consisting of items regarding
the research process, the actors and their organizational
environment, the interaction between actors, and the
contributions in the three phases of knowledge production,
all based on the CM evaluation method. An additional file
shows this in more detail (Additional file 2 Topic List
interviews actors Case Study Risk Model). The RIVM prin-
cipal investigator, who was also involved in the Risk Model
project, conducted the semi-structured interviews face to
face. Each interview lasted approximately one hour and
was recorded and transcribed verbatim.
After importation of the data into Atlas-ti version
6.2.25, the principal investigator analyzed the data by
coding [11]. We based the code list initially on the
conceptual framework and completed it with inductive
codes. The coding of the interviews started while data
collection was ongoing and the topic list for the inter-
views was iteratively adapted in order to achieve data
saturation. Three other investigators independently coded
two interviews and we validated the coding in an open-
coding session (agreement 72%; response 70%).
Based on the documentary analysis and interview data,
we constructed a map of the research project according
to the method CM by assessing the course and contribu-
tions of the project [7].Feedback session
Next, we organized a feedback session with two inspec-
tors, a manager from the Inspectorate, the RIVM
project leader, and a RIVM manager, to present and
discuss our findings. All those present gave their feed-
back on the draft assessment and discussed actions for
improving contributions and interaction. This discus-
sion was recorded and transcribed verbatim. Based on
the findings and the outcome of the feedback session,
we drafted the final version of the contribution map
and we inductively identified six categories of relevant
alignment efforts.Results: the research process and its contributions
In this section, we present the course of the research
process based on the data collected by documentary
analysis and the interviews. We identified contributions
in three categories: the utilization of the produced
knowledge by inspectors, investigators and their organi-
zations (contributions through linked utilization), the
project’s knowledge products (contributed knowledge
products), and changes in abilities and actions by inspec-
tors, investigators and their organizations due to the
research project (change in involved and linked actors).
Contributions through utilization at-a-distance, the fourth
contribution category distinguished by Kok and Schuit,
did not emerge due to the confidential nature of the
knowledge products [7]. In brackets, we name the identi-
fied contributions and the occasions where we observed
the presence of alignment efforts.Background of the project
The Risk Model project lasted for three consecutive
years with an extension in the fourth year (2007–2010;
Figure 3). According to the yearly cycle for RIVM re-
search, the Inspectorate submitted a knowledge question
for every project year to which the RIVM made a corre-
sponding offer. For every project year, we distinguish the
three phases according to CM:
i. The period for submitting the knowledge question
and writing the project plan in an RIVM offer (from
July until December; in the preceding year;
formulation phase);
ii. The period for performing the planned research
activities (from January until the delivery of all
agreed knowledge products; production phase);
iii. The period after delivery of agreed knowledge
products (extension phase).
The project aimed to develop a risk-based approach
for clinical trial inspections in the Netherlands and had
to deliver risk models to enable ranking and stratified
selection of clinical trials for inspection. The research
activities included the identification of risk factors and
risk indicators and the development of two risk models:
one for clinical trials on medicinal products (1st year)
and a second for clinical trials on food substances (3rd
year). We consider the models contributed knowledge
products according to CM. To create these knowledge
products, a synthesis of scientific knowledge on risk-
ranking, risk models, medicinal products, and food sub-
stances was made and combined with legal and practical
knowledge on clinical trials and inspections. This re-
sulted into a new risk-based approach to clinical trials.









Implementation risk model 1
Development risk model 2













Figure 3 Timeline for the risk model project. Timelines of the Risk Model project visualizing the formulation, production, and extension phase for
the three project cycles. In the formulation phases, the knowledge questions (KQ) were: i) the development of risk model 1 (KQ 1), ii) the implementation
of risk model 1 (KQ 2; postponed to project cycle 3), and iii) the implementation of risk model 1 and the development of risk model 2 (KQ 3). In the
production phases, the following activities took place: i) the development of risk model 1 (production phase 1), ii) no activities, project in sleep mode
(production phase 2), and iii) the implementation of risk model 1 and the development of risk model 2 (production phase 3). Risk model 1 has been
used in extension phase 1, risk model 2 has not been implemented or used.
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without involvement of other organizations.
Development of the first risk model
During the first formulation phase, the RIVM project
leader and the contact person of the Inspectorate agreed
to focus on clinical trials on medicinal products (align-
ment efforts; Formulation Phase 1).
Although in line with the official policy plan of the
Inspectorate, the inspectors emphasized that it was not
the driving force behind their research question; they felt
the need for a tool for risk-based selection of inspection
objects because of the overwhelming number of clinical
trials they had to supervise (about 1,800 approved proto-
cols each year). Although the inspectors were of the
opinion that they had the expertise and competencies
themselves, they had no time to develop a method for
risk-based selection. They formulated an official RIVM
knowledge question including distinct ideas for the
approach of the problem and the design of a tool.
Inspectorate Manager 1: “The knowledge question came
up because of the enormous amount of inspection objects
and the small number of inspectors involved. They tried
to find a sensible way for risk-based selection.”
At the RIVM, the origin of the research question was less
clear. Some RIVM respondents thought the Inspectorate’smanagers ordered the risk-based approach because of
the official policy.
Researcher 1: “I think that the knowledge question
came from higher quarters, because of the general wish
to have more risk-based supervision, just because of
the general principle and to have a model for it.”
After the formal start of the first production phase, it
took several consultations to refine the research question
and to agree upon the way to go (alignment efforts;
Production Phase 1). This exploring phase in the pro-
duction phase took longer than foreseen by the RIVM
investigators in the project plan and caused delay. The
data accessibility appeared to be much more problematic
than anticipated, because the Inspectorate could not
directly access the clinical trial database that is in control
of another governmental organization, which largely hin-
dered the development of the risk model.
The research team consisted of three RIVM investiga-
tors, who cooperated closely with three inspectors. During
meetings, they discussed the scientific approach of risk
ranking, risk factors, indicators, and draft versions of the
risk model (alignment efforts). The project resulted in an
electronic risk model and a report on its development
(contributed knowledge product).
The transfer of the knowledge product by mail was
without any project-specific dissemination activities and
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Phase 1). After transfer, the inspectors mentioned to the
investigators that their management criticized the risk
model. However, the inspectors internally solved the
issue and the nature of the criticism never became clear
to the investigators. In the interviews, the Inspectorate’s
managers expressed some critical remarks on the scientific
approach of the risk model but also mentioned that the
inspectors involved were contented with the model and
that this was decisive for accepting the knowledge product.
Researcher 1: “And I became aware that manager 2 at
the Inspectorate had a negative opinion and we asked
for more explanation, but we never received it.”
Since the risk model was considered an internal confi-
dential inspection tool, the Inspectorate requested to
keep the model confidential. The RIVM agreed although
it meant that they could not further publish it nor use it
in scientific discussions on risk-based supervision (align-
ment efforts).
On their side, the inspectors did not disseminate the
risk model, neither in their external network due to its
confidential status nor within the Inspectorate, because
they were of the opinion that the risk model was too
specific for other disciplines within the Inspectorate. The
only occasion they exchanged the risk model was during
the discussion with another governmental organization to
get access to the clinical trial database (contributions
through linked utilization). Nevertheless, they shared their
experiences with the model in international discussions
on risk-based inspections (contributions through linked
utilization). The Inspectorate also mentioned the existence
of the risk models in public presentations, in publications,
such as annual reports, and in a formal answer to ques-
tions of the Parliament (contributions through linked
utilization).
Project in ‘sleep mode’
During the second formulation phase (that coincided
with the first production phase), the Inspectorate formu-
lated a new knowledge question: their intention was to
incorporate the risk model in their operating procedures
and they asked for RIVM assistance in the implementa-
tion (Formulation Phase 2).
After the official start of the second production phase,
it eventually became clear that the inspectors could not
realize the implementation of the risk model due to
shortage of staff at the Inspectorate. Consequently, they
did not need RIVM-assistance and the project went into
‘sleep mode’ (Production Phase 2). In fact, the yearly cycle
was broken due to unforeseen circumstances and the
Inspectorate officially postponed this knowledge question
to the next (third) year.Implementation and a second risk model
For the third year, the knowledge question included both
assistance at the implementation of the risk model and
the development of a second risk model for another cat-
egory of clinical trials (Formulation Phase 3). In their offer,
the RIVM investigators did not yet define the category of
clinical trials for this second model, but mentioned two
options as an example. They stipulated that the choice for
the new category should depend on the availability of
appropriate data after an inventory of available data.
An RIVM investigator assisted at the implementation
of the risk model for clinical trials on medicinal products
and adapted the original model in order to facilitate data
import into the model (alignment efforts; Production
Phase 3). In June, a short report was presented to the
Inspectorate on the progress, including the adapted elec-
tronic risk-ranking tool for clinical trials on medicinal
products (contributed knowledge product).
For the second risk model, the investigators and
inspectors initially disagreed on the category of clinical
trials. Due to a serious incident in a Dutch hospital in
the previous year, the inspectors wanted clinical trials on
food substances to be the focus of the second model.
The investigators preferred clinical trials on medical
devices based on the analogy to medicinal products,
more available data and the match with their own
expertise. However, the Inspectorate’s reality is that they
also have to take into account the public and political
circumstances when setting priorities in supervision and
they felt the need to develop a risk model for a category
that was less obvious for the researchers. This caused
some tension in the project between investigators and
inspectors, which was eventually resolved by discussion
(alignment efforts).
The development of the new risk model for clinical tri-
als on food substances needed extra unforeseen time
and was not delivered according to the project plan but
in the following (fourth) year (contributed knowledge
product). During the finalization phase, only the RIVM
project leader was involved and occasionally consulting
other investigators. The model was again confidential
and not published on the RIVM website. The second
risk-model on clinical trials with food substances was
never used (Extension Phase 3).
Interviewer: “What is your opinion about the second
model, did you use it?”
Inspector 3: “No, I cannot say anything about that
because we did not use it until now.”
Interviewer: “Could you indicate what the reason is?”
Inspector 3: “Mainly because of competition with other
tasks or other inspections. There were other issues with
priority: international inspections and the thematic
inspection project. And because the priority of the
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incident was dealt with and the interest in these
inspection objects diminished.”
Sequel to the project
The investigators and inspectors had differing views on
the desired sequel to the project which uncovered differing
views on the ownership of the knowledge products. On one
hand, the investigators regarded the risk models as their
own knowledge products or at least co-creations with co-
ownership of both parties. They expected that further devel-
opment of the risk models would also evolve in co-creation
by RIVM and Inspectorate and that they would spontan-
eously receive feedback on user experiences with the model.
Researcher 1: “…I have the opinion that they should
exchange this kind of information spontaneously.”
The inspectors presented their risk ranking experi-
ences in EU expert meetings, but did not provide feed-
back to the investigators; they were not aware that
international discussions on a risk-based approach were
of high interest to the investigators. They regarded the
risk models as their own products and they choose not
to involve the investigators in the evaluation and further
validation of the models. The confidentiality of the prod-
ucts conflicted with the investigators’ interest to publish
the reports and to use the findings in international dis-
cussions. Although both RIVM management and the
investigators agreed with the required confidentiality,
these differing expectations were discussed neither at
the start nor at the end of the project causing unarticu-
lated tension.
Appraisal of contributions
All inspectors were rather satisfied with the contributions
of the project to their work. In their opinion, they had
used the risk models as much as possible and they
expected further use, validation, and development of the
models in the future (alignment efforts). However, the
need for linking the risk models directly to the clinical
trial database became gradually evident after transfer, but
access to the database remained problematic. Without
linkage to the database, the risk models turned out to be
too laborious. Nevertheless, the inspectors were deter-
mined to move on with the models in coming years.
Inspector 2: “Yes, I feel positive about it. Especially
inspector 3 used it and in that sense I have the impression
that the worksheets, the Excel sheets, function properly.”
The Inspectorate’s managers were positive about the
project afterwards, merely because the inspectors as
users of the models were positive (alignment efforts).However, they showed some reserve since the risk
models could only be in full use if connected to the clin-
ical trial database. Given that this feature was not
yet realized, the risk models had not taken away the
managers’ concerns about the supervision of clinical
trials. They still felt the need to have ways to predict
specific, yet unknown risks in order to be able to prevent
incidents and they doubted whether the current feature
of the risk models was suitable for this purpose.
Inspectorate manager 2: “We should think more about
what we want to know and what we want to do with
it at the start. We consequently do nothing with the
report. Although this was not a bad example after all,
since the inspectors felt contented about it. But it can
be improved.”
On the other hand, the RIVM investigators assessed
the contributions of the project to the Inspectorate’s
work as minor. After transfer, they were insufficiently
acquainted with the implementation problems at the
Inspectorate. They had expected that the risk models
would be used on a daily basis within two or three years.
Researcher 1: “I expected that we would establish a
model able to scan all clinical trials within a
maximum period of two, three years.”
Interviewer: “For all trials?”
Researcher 1: “For all trials, yes, but to achieve that
more thinking, more communication was needed and
it had to be done faster. But it did not work out that
way…”
At the site of the RIVM, the project contributed to the
implementation of their strategy to extend the research
area of the centers specialized in the quality control of
medicinal products. The required expertise on risk rank-
ing was on the fringe of the traditional expertise of the
RIVM centers involved and the project offered the oppor-
tunity for developing new expertise (contribution ‘change
in involved and linked actors’). However, this contribution
was hindered by the confidentiality of the risk models.Consultative structure
In this study, we paid special attention to the interaction
in all phases of the research project and we also found
that all interviewed persons in this case study recognized
the importance of their interaction to enhance the
contributions of the research project. We asked them
to indicate which factors could improve the process
and contributions, and they all spontaneously indicated
that the relationship and interaction like meetings and
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research project.
During the phase of formulation, the investigators and
inspectors had only limited interaction. The formal pro-
cedure agreed between the Inspectorate and RIVM does
not facilitate in-depth discussion on the knowledge
question and the project plan due to the very formal
deliberations at management level, short time periods,
and strict deadlines within the procedure.
Inspectorate Manager 2: “The more the question is
vague, the more RIVM is not able to make a proper
offer. If it is too unarticulated, the RIVM should not
accept the question. What would the offer be based
upon, which expertise and how many research hours?
We should have more interaction.”
During the production phases, the consultations went on
in a good atmosphere according to both parties. In meet-
ings, the inspectors and investigators openly discussed the
risk factors and drafts of the risk model (alignment efforts).
Inspector 4: “It was according to an established
pattern. We discussed what we as inspectors thought
about the results so far and then the RIVM got the
work again to improve (the drafts).”
The frequency of the consultations between RIVM and the
Inspectorate depended much on proactive organization, avail-
ability of persons, and priorities at the Inspectorate (alignment
efforts). The interaction between investigators and inspectors
often suffered from time constraints and the inspectors and
investigators experienced this in a different way.
The inspectors considered the frequency of interaction
overall rather high and satisfactory, especially in the first
year. The investigators emphasized that the lack of time of
the inspectors to give feedback on drafts of the risk model
resulted in delay. Although the inspectors regretted that their
own time constraints delayed the evaluation and further
development of the model, they accepted this fact of life.
Inspector 2: “At the start, I think the intensity was very
adequate, meetings on fixed time points. It is my feeling
that there was need for it. The meeting dates were
planned, but only used if needed. At a certain point in
time, my role changed and I did not take part in
everything anymore and therefore it is difficult for me to
assess. It is my impression that it was less frequent for
the extra model; however, this was the second project
and things were clear already. So, although less
frequent, it was sufficient in relation to the need.”
Interviewer: “What is your view on the interaction
with the inspectors?”RIVM Manager 2: “With great difficulty, at least
between RIVM and Inspectorate and I have the
impression that the inspectors get so many stuff and
small issues on their desks that they have difficulty to
pay attention to structured campaigns and they spent
a lot of time in acting in a reactive way. I suppose…,
this is my impression.”Organizational environment
At the RIVM, the Risk Model project was a rather iso-
lated project that lacked solid embedding in the research
organization because the project was unusual and small
in terms of people involved and research hours available.
Colleague investigators were busy with the regular, large
projects and not very interested because of the limited
link with their research activities. The investigators had
a few deliberations with their management to monitor
the progress of the project at formalized moments
(alignment efforts). The managers controlled the finances
and timely output, but maintained their distance to the
project and only commented on drafts of the final report
(alignment efforts). At management level, meetings be-
tween the Inspectorate and the RIVM only focused on
general issues and the Risk Model project was never
discussed. The managers discussed neither the contri-
butions of the project nor a way out for the confidential
status of the knowledge products in order to facilitate
publication of findings.
Investigator 2: “We worked rather solitary. I
experienced it as an isolated project, detached,
isolated. It was not attached to other projects at all. It
was not interwoven with the RIVM network.”
An important finding was the major influence on the
project of the established relationship between both
RIVM and the Inspectorate. In the interviews, the
inspectors, investigators, and managers expressed strong
ideas of the other organization and we observed diver-
gent views on the mutual relationship. At management
level, the budget system was always an important
issue since the Minister of Health does not allow the In-
spectorate to use their dedicated RIVM-budget for
commissioning research to other organizations. The In-
spectorate considered the system therefore as a forced
sourcing system without competitors for the RIVM
and without sufficient possibilities to influence the
RIVM research proposals. This view is in contrast with
the perception of the RIVM managers and investigators,
who considered their research for the Inspectorate as
working on a mutual governmental task and experienced
the Inspectorate’s view as unjustified distrust of their
organization.
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view on the RIVM. Not with respect to their quality, but
because we have this forced sourcing at the RIVM.”
RIVM manager 1: “The Inspectorate relies on RIVM
results, but the forced sourcing reflects the relationship
and this causes lack of trust.”
On their side, the RIVM managers experienced that lack
of time largely determined the quality of the Inspectorate’s
commissioning role often resulting in unarticulated re-
search questions. Because the RIVM accepted all research
questions, this often led to unsatisfactory contributions of
research projects.
RIVM Manager 1: “So it was a knowledge question
and actually, you were told to elaborate it per
definition. So the only choice we had, was to choose
the way to deal with the knowledge question, but not
whether you should deal with it at all, that was no
consideration at that time.”
Discussion
Relevant alignment efforts
Analyzing the course of the Risk Model project and as
indicated in the findings, we observed alignment efforts
made by both RIVM and the Inspectorate; investigators,
inspectors, and managers tried to create alignment
within the bounds of their reach, both according to the
institutional procedures at stated moments and accord-
ing to the circumstances in the project. The importance
of well-organized interaction between the networks RIVM
and the Inspectorate is recognized on an institutional
level; the RIVM and the Inspectorate have agreed upon
transparent formal procedures to streamline the yearly
commissioning process and to monitor the course of the
agreed research projects. The Risk Model project was
managed according to these formal rules and procedures.
De Leeuw et al. [12] described a classification of 30 differ-
ent theoretical frameworks for dealing with action on the
nexus of research, policy, and practice. They established
three groups of seven categories of theories, one of them
the category Institutional Re-design. This category com-
prises theories that acknowledge the importance of in-
teractions between actors from different institutions,
which results in the explicit management of these inter-
actions by maintaining institutional arrangements and
establishing institutional rules. In our view, alignment
efforts by the formal procedures match with strategies
in the category Institutional Re-design. For both RIVM
and the Inspectorate, alignment rules and guidelines
were top-down established and explicitly encouraged
project leaders and contact persons to interact with
their counterpart at the other organization duringformulation and production phase of a research project.
Their management boards jointly discuss and revise
regularly the agreed procedures to improve commis-
sioning process. For the extension phase, the RIVM
procedures provided guidance and rules for the presen-
tation and lay-out, formal approval by the management
and the transfer of contributed knowledge products.
Despite these institutionalized alignment efforts, we ob-
served difficulties that could be attributed to lack of align-
ment at the level of the research project. Based on the
course of the project and the contributions as described in
the results section, we inductively identified six categories
of alignment efforts that were relevant for the project.
Relevance: discussing the research results and their
relevance for the commissioner and attuning the
presentation of the knowledge products to the needs of the
commissioner
Our findings show that the investigators and inspectors
translated the need for alignment mainly in alignment
efforts on ‘relevance’. The importance of alignment was
in fact well recognized by the investigators and inspec-
tors in the Risk Model project; they developed the two
risk models as much as possible in close collaboration.
During the production phase, alignment efforts primarily
focused on discussing the concepts and drafts for the
risk models and on the design of the electronic tool.
From the perspective of both investigators and inspec-
tors, alignment efforts on relevance were crucial for
successfully accomplishing the research project. The in-
vestigators had to account for both scientific quality and
customer satisfaction and the inspector’s interest was to
get timely knowledge products that fitted to their needs,
which required alignment on the level of the scientific
aspects and the presentation of the results.
Together, they also had to deal with the tension that
exists in commissioned RIVM research projects; the
RIVM has an independent status established by law and
in principle, the commissioner cannot determine re-
search methods, influence the outcome of studies or
prevent publication of results [1]. At first sight, the for-
mal independent RIVM position conflicts with the need
to align on ‘relevance’ issues. Here, the concept of back-
stage and frontstage work formulated by Goffman is
helpful to overcome this contradiction [13]. Bekker et al.
[14] described the RIVM as a boundary organization in
the context of the Public Health Status and Forecasts
(PHSF) reports and the biannual Dutch Health Care
Performance reports. As a boundary organization, RIVM
projects act as intermediary entities into which organiza-
tions delegate actors to contribute to the research and
where frontstage and backstage work are combined in
order to enhance the influence of the reports in inform-
ing public health policy. At the frontstage, organizations
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the backstage, informal alignment paves the way for the
organizations’ accountability at the frontstage. By ana-
logy with the PHSF, the RIVM research projects for the
Inspectorate could also be considered boundary areas
where research for the benefit of the Inspectorate is
performed and investigators, inspectors, and their man-
agers collaborate. From this perspective, the formal
agreed procedures represented the frontstage work to
account for the organizations’ roles in the commission-
ing process. The meetings between the investigators and
inspectors and their informal interaction at a personal
level can be considered the backstage.Consultative structure: agreeing on and acting on the
consultative structure
For the Risk Model project, a limited consultative struc-
ture existed that mainly focused on the production
phase. Van Egmond et al. [15] described the infrastruc-
ture developed by the RIVM for the above mentioned
PHSF report, indicating that the backstage was well-
organized, and presented it as an example for successful
boundary work. However, in the Risk Model project, a
backstage area at the start of the new project hardly
existed and backstage work was limited to a few phone
calls. Ample opportunity for backstage interaction, already
in an early phase of the research project, will enhance the
identification of possibly influencing factors and trust
between actors and thus improve the process and its con-
tributions. For the third project year, the opportunity
existed to discuss the next year’s project plan during the
regular meetings, but this opportunity was not intensively
used. This shows that backstage work is not only a matter
of available time, but also of culture and relationship
between organizations. As argued by Wehrens et al. [16],
a well-functioning boundary organization needs “internal
room to discuss different perspectives, goals and expecta-
tions (and to find a balance that satisfies everyone in-
volved) while the legitimacy of the activities, products and
projects is not questioned in the broader organizations of
the participants.” For the case of the Risk Model project,
the internal room for backstage work was limited due to
priority setting in both organizations and the relationship
between RIVM and the Inspectorate that interfered with
open discussion. The transition from the informal back-
stage to the formal frontstage was not clearly marked
since the project continued for several years and, each
year, new backstage work had to be done. Inspectors had
to take both frontstage and backstage positions at the
same time, causing confusion at the side of the investiga-
tors. In fact, the backstage was not very well developed
and the organizations did not sufficiently recognize its
importance in relation to the frontstage.According to Wehrens et al. [16], the backstage and
frontstage of organizations have different functions but
are interrelated and cannot exist independently of one
another. In most cases, the frontstage is predetermined
by official arrangements that can even be emphasized by
a ceremonial public presentation of the knowledge prod-
uct to the commissioner. However, in the Risk Model
project, the frontstage was marginalized because of the
requested confidentiality of the risk models. Because of
this, the Inspectorate did not have to account for using
the risk models, which distorted the backstage space and
made the investigators confused about the demarcation
of backstage and frontstage.
Goal and timing: discussing and agreeing on the
formulation of the knowledge question, its origin, the
question behind the knowledge question, and the
underlying need for the knowledge products
For three consecutive years, the Inspectorate formulated
knowledge questions for the Risk Model project. The
procedure for commissioning research to the RIVM was
rather formal, with strict deadlines, and included several
management levels for approval. The management regu-
larly updated the rules with the intention to improve the
research projects and their contributions. These formal
procedures are important for legitimization of the re-
search projects, but offered limited opportunity for
alignment efforts at the investigator and key user level in
the formulation phases. Although the formal alignment
efforts with respect to the goal and timing of the project
were in line with the established procedures, several in-
terviewees mentioned that more informal interaction
during this phase of a research process could improve
its contributions. These findings are in line with the crit-
ical key factors identified by De Goede et al. [9] to influ-
ence the expectations of research users. Early extensive
alignment efforts between investigators and key users on
the formulation of the research question using previous
experience and researchers’ knowledge, exploring the ac-
tual needs behind the question, and taking into account
study limitations is important to manage the expecta-
tions on the contributions and achievable timelines at
both sides.
Tasks and authority: explicit discussing of the relationship
between actors and agreeing upon input and role of actors,
responsibilities, sharing of information and knowledge,
authority over the contributed knowledge products, and the
follow-up of the research project
In the Risk Model project, the RIVM project proposals, as
presented in the formal offers, were designed according to
the formal guidelines and approved by both the RIVM
management and the Inspectorate. However, the guidelines
did not explicitly require consideration of time investment
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products, the exchange of confidential information, and the
follow-up of the project, whereas these issues caused fric-
tion later in the project. The alignment strategies based on
the Institutional Re-design approach were not able to meet
the need for mutual understanding between organizations
at project level. Another category of theoretical frameworks
described by De Leeuw et al. [12] is the Blurring the
Boundaries model. In this model, the actors of organiza-
tions involved learn about each other’s world by obtaining
access to it. In our study, a notable finding was that the
RIVM and the Inspectorate afterwards differently assessed
the contributions of the project, the interaction during the
research process, and the ownership of the knowledge
products. Investigators and inspectors had different actor
scenarios, but were not aware of this. This illustrates the
need for more alignment strategies based on the Blurring
the Boundaries model. Understanding each other will gen-
erate more trust and confidence, better recognition of per-
ceptions and more open discussions on sensitive issues.
Every actor in a research process has his/her own scenario
and perspectives for the future of the research project
contributions. If investigators are aware of the changing
circumstances in the commissioner’s organization and
understand the role knowledge and research projects have
in the commissioner’s scenario, they will be better able to
promote the research contributions.
Vertical alignment: sharing information within the own
organization and embedding of the research project within
the own organization
In the literature, the importance of horizontal alignment
between research and key users is exhaustively described;
horizontal alignment efforts are considered the key for
enhancing research contributions. We observed that also
the vertical alignment within the own organizations of both
investigators and inspectors was a very relevant factor for
the research process and its contributions. Some difficulties
in a project with respect to tasks and authority, relevance,
and organizational environment cannot be tackled by in-
vestigators and linked actors at a project level and will often
ask for a combination of horizontal as well as vertical align-
ment efforts at different levels in the organizations. The
embedding of Risk Model in both RIVM and the Inspector-
ate was limited and the management was hardly involved
during the production process, while their alignment efforts
focused on general issues and not on project-specific issues.
We argue that explicit vertical alignment efforts could
bring project-specific issues to the attention of the manage-
ment level at which horizontal alignment efforts could
really enhance the solutions. The required confidentiality
of the risk models serves as an example of a fundamental
issue where vertical alignment efforts were lacking. The
Inspectorate desired confidentiality because publicationwould also mean that they had to justify the selection cri-
teria in the risk models to outside stakeholders and that
they could no longer diverge from the selection method.
On the other hand, the RIVM’s task and interest was to
deliver scientifically legitimate knowledge products and, to
achieve this, both the necessity of stakeholders’ involve-
ment and publication of the risk models should have been
considered. The inspectors were bound to their own orga-
nizations’ policy and the investigators met the require-
ments of the commissioner. Vertical alignment efforts on
project-specific issues would have identified the different
views of RIVM and the Inspectorate at the appropriate
organizational level at an early stage and could have
resulted in a more grounded RIVM position on the owner-
ship issue and scientific approach.
Organizational environment: aligning with respect to
relevant conditions outside the research project influencing
the relationship between investigators and linked actors
and/or the research project, such as changing priorities,
incidents, media-events, and relationship with other
organizations
In the formulation phase, a new research project is dealt
with as a well-defined assignment that can be planned
and controlled by the project manager. In reality, the
research project and its actors are part of a complex
organizational environment that continuously changes
and influences the course and contributions of the pro-
ject. In the Risk Model project, we identified several un-
expected influencing factors from the Inspectorate’s
organizational environment, such as data accessibility,
time investment by the inspectors, and a serious incident
that influenced the second risk model. At the RIVM site,
implicit, not openly discussed organizational circumstances,
such as the project’s embedding in the organization and the
historical relationship between RIVM and the Inspectorate,
appeared to be influencing. On the one hand, both in-
vestigators and inspectors did not exactly know and
understand the underlying feelings and motives of the
other organization and their alignment efforts focused
mainly on the scientific issues. On the other, the pro-
ject’s backstage did not sufficiently facilitate reflection
on the project to develop feelers for influencing factors
from the project’s organizational environment. Conscious
alignment efforts on the organizational environment
would require more trust and understanding as argued
in Blurring the Boundaries models combined with a
well-developed backstage to accommodate discussions.
Reflection on contribution mapping (CM)
The evaluation method of CM aims to offer a practical
and realistic approach to evaluate the contributions of a
research project and to analyze the alignment efforts. In
CM, both key users and investigators have an active role
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session. Due to these characteristics, this method can be
considered a fourth generation evaluation method [17].
The criteria for assessment of contributions and alignment
efforts are not fixed beforehand, but are based on issues
that emerge from the interviews. In our view, this respon-
sive evaluation was useful to unravel a research project
such as Risk Model, the contributions of which remained,
on the face of it, unclear. To elucidate our questions
on research contributions, a qualitative approach taking
into account the actors’ own issues and their social
process was needed to find clues for improvement on both
organizational and project level. By using CM, we indeed
gained an illuminating insight in the course of the Risk
Model project. The interviews delivered a rich data set
that disclosed the contributions and alignment efforts.
When presenting these findings to inspectors during the
feedback meeting, investigators and managers recognized
the analysis and findings, which adds to the validity of the
analysis. The feedback meeting gave opportunity to dis-
cuss the differing views, to exchange experiences, and to
formulate concerted actions to solve identified issues.
We would like to comment that for a small project such
as Risk Model, the number of interviewees can remain
limited to get a complete overview. For a major project, we
expect that this would require a proportional number of
interviews with a corresponding workload. Depending on
the aim, CM users could consider focusing only on specific
key users in order to conduct the CM with achievable effort.
Another possibility for selective application of CM is to
choose a project as a typical example in a specific context.
In this case study, we recognized patterns and issues that are
directly applicable to other RIVM research projects as well.
The concept of contributions was very helpful to iden-
tify the (added) value of the project for the Inspectorate’s
work. The project’s attributed value manifested itself not
as expected, but could be demonstrated by the concept
of ‘contribution’. The CM method does not focus on
assessment of the contribution category ‘utilization on
distance’. In our case, this was not a drawback because
of our focus on contributions to the commissioner’s
work to improve RIVM projects.
Although the first aim of the feedback session was to
add information to the collected data from interviews
and document analysis, we experienced that such a
feedback session is an alignment strategy in itself. We
drafted an abridged report of the discussion on which
the participants commented. The consensus report in-
cluded several recommendations for improvement of the
knowledge production process to be taken aboard for
future projects and a proposal for a pilot to test the
recommendations in a number of new projects. We sent
the report to managers within both organizations, and
we therefore consider the feedback session as a veryuseful three-layer part of the case study; the scientific
data collection layer where participants were able to add
information or to comment on findings; an alignment
strategy in itself since the participants solved issues
during the discussion; and a method to improve the
research process.
By joining a systematic evaluation session, participants
can learn how to improve the research process [18].
Although in our case all participants valued the feedback
session in this respect, we experienced that the formulated
actions for improvement did not automatically result in
better research processes in actual RIVM projects since
the agreed actions were subject to the same alignment
problems as the project and turned out to be more com-
plex than expected during the feedback session. We argue
that a carefully planned and managed follow-up would be
the fourth prerequisite of a successful feedback session.
Study limitations
We have to mention some limitations of this study. The
principal researcher of this study was also involved as
an investigator in the Risk Model project. As an RIVM
investigator, she is also involved in other projects for the In-
spectorate at present. On one hand, she had the advantage
of having inside knowledge about the research process and
the context of the case. To overcome the disadvantage of
being biased by own experiences, the coding of the inter-
views was validated by three other researchers not involved
in the Risk Model project. The research team intensively
discussed the analysis of the findings. Moreover, the find-
ings were also discussed with the participants of the feed-
back session. Combining all feedback, we conclude that
consensus on the analysis exists within the research team.
In this article, we describe the first case in a multiple case
study on the contributions of government-commissioned
research projects. For this multiple case study, the different
cases are selected to cover a variety of characteristics
that may influence the research process and its contri-
butions. This first case was a relatively small research
project within the specific context RIVM-Inspectorate.
This questions to what extend the findings can be gen-
eralized to other research projects. Our findings were
largely in line with our expectations based on the study
framework. According to CM, inspectors, the RIVM
project leader and managers, and the Inspectorate dis-
cussed the contribution map in a feedback session.
They agreed on the findings and identified general
issues that also emerge from other research projects.
Moreover, we presented the final contribution map in
several scientific meetings in the RIVM. The influence
of limited interaction, organizational environment, and
relationship with other organizations is widely recog-
nized, also by investigators operating in other expertise
fields and working with other commissioners. Although
Hegger et al. Health Research Policy and Systems 2014, 12:8 Page 14 of 15
http://www.health-policy-systems.com/content/12/1/8this case study describes a specific and small project,
we consider the findings relevant for government-
commissioned research projects. However, we will have
more insight in the generalizability of this case after
completion of all cases in our multiple case study.
Conclusions and recommendations
By analyzing the course of the Risk Model project and
its contributions, we wanted to establish which alignment
efforts are important for the RIVM-Inspectorate context in
order to find clues for improving the contributions of RIVM
projects. We identified six categories of relevant alignment
efforts that can be undertaken at three different levels: at the
first level, alignment efforts between investigators and linked
actors; at the second level, alignment efforts related to the
organizational environment of the project appeared also to
be important; at the third level, alignment efforts between or-
ganizations as part of their formal and historical relationship.
At the first level, investigators and linked actors can
improve alignment by continuous reflection on actor
scenarios, awareness of mutual expectations, and open
discussions with commissioners at all levels in the
organization. This will ask for substantial efforts from
all actors involved and will take precious (research)
time for interaction on an ongoing basis.
At the second level, more awareness of the importance of
the organizational environment could help to formulate an
adequate response to challenges for the research project for
which vertical alignment efforts can be essential. Since the
vertical alignment efforts turned out to be of influence, the
focus in a research project should not only be on the exter-
nal alignment efforts. Attention for the role of internal
interaction, both at the level of the project as well as man-
agement level, and a good institutional embedding could
improve the research process and thus its contributions.
At the third level, alignment efforts are more difficult to
deal with; the historical relationship of the institutes deter-
mines their views on each other at all organizational levels
and thus influences the interaction during the research
process. This ‘soft side’ of the project can be hard
to manage and therefore a collective approach at all
organizational levels should be developed. It could be
useful to openly discuss the historical relationship and
its influences on the interaction within, and even be-
tween, organizations. We suggest that both research
organizations and commissioning bodies should invest
time and energy in regularly organized reflection ses-
sions where both researchers and managers openly
analyze and discuss the relationship with other organi-
zations. This also implies that maintenance of this
awareness will be important since collective views and
memory also influence new actors. If all actors are con-
tinuously aware of the historical context and relational
aspects of their research projects, they could anticipateon the implicit consequences and improve their align-
ment efforts. At the strategic organizational level, align-
ment efforts should focus on the organizational image
to increase trust and legitimacy in order to overcome
historically determined, yet invalid frames.
Based on the findings, we recommend that a research in-
stitute should encourage a reflective attitude towards the
social aspects of research projects at all levels in the
organization. The first step for improvement is to validate
the importance of the process factors for a new project; the
second step would be to calculate in the need for time for
these aspects of the research process at the start of the pro-
ject. This will facilitate the third step to anticipate explicitly
on alignment efforts during the research process. With
respect to the evaluation of a research project, we experi-
enced that CM offers an alignment effort in itself, apart
from being a useful instrument to evaluate a research pro-
ject. The feedback session as part of CM yielded not only
information about the research process and its contribu-
tions but also elicited awareness and preparedness for im-
proving research processes at the side of the participants.
CM can therefore be a useful instrument in reflections
on contributions and research processes. Nevertheless,
one should be aware that a feedback session needs carefully
planned follow-up in order to improve the research
process; the jointly formulated actions are in fact new
projects themselves and need no less alignment efforts
than other projects.
Organizations, investigators, and all other linked actors
should be encouraged to experience the profits of social
investments in research projects and should be rewarded
for doing so. To achieve this, different strategies based on
different models should be considered. Institutional rules
incorporated in the organizations ‘quality system’, can
facilitate project teams, but should be coupled with
sufficient room for well-organized backstage work with
involvement of actors familiar in both organizations. The
challenge is to convince organizations and their staff
to consider alignment efforts as a valuable dimension of
research projects, instead of extra burden, because of its
influence on project contributions and on trust in and le-
gitimacy of the organization in a broader sense.Additional files
Additional file 1: Yearly cycle for RIVM research in commission of
the Health Care Inspectorate. Textbox describing the yearly research
cycle of the RIVM: the formulation of the knowledge question by the
commissioner, the corresponding RIVM offer, the research phase, and
finally, the delivery of the agreed knowledge product.
Additional file 2: Topic list interviews actors Case Study Risk Model.
The topic list for the interviews consists of items regarding the research
process, the actors and their organizational environment, the interaction
between actors and the contributions in the three phases of knowledge
production.
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